Related Experiment Video
Updated: Apr 6, 2026
08:39
Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation
Published on: November 7, 2020
8.6K
Risk factors for recurrent primary sclerosing cholangitis after liver transplantation
Reena Ravikumar1, Emmanuel Tsochatzis1, Sophie Jose2
1Sheila Sherlock Liver Unit and UCL Institute for Liver and Digestive Health, Royal Free Hospital, London, UK.
Journal of Hepatology
|July 19, 2015
Summary
Recurrent primary sclerosing cholangitis (rPSC) after liver transplant is linked to ulcerative colitis (UC) and younger age. rPSC significantly increases graft failure and mortality risk in PSC patients.
Area of Science:
- Hepatology
- Gastroenterology
- Transplantation Immunology
Background:
- The association between primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD) is established.
- The relationship between IBD and recurrent PSC (rPSC) post-liver transplantation requires further investigation.
- Understanding rPSC prevalence and associated factors is crucial for improving outcomes in PSC patients undergoing liver transplant.
Purpose of the Study:
- To determine the prevalence of rPSC in patients with PSC undergoing liver transplantation.
- To identify factors associated with the development of rPSC.
- To evaluate the impact of rPSC on graft and patient survival post-liver transplantation.
Main Methods:
- A UK multicentre observational cohort study included patients undergoing their first liver transplant for PSC between 1990 and 2010.
- Data on liver transplantation were prospectively collected, while colitis data were retrospectively gathered.
- Statistical analysis, including hazard ratios (HR), was used to assess associations.
Main Results:
- Of 679 first transplants for PSC, 347 patients had IBD (306 with ulcerative colitis).
- 81 patients (14.3%) developed rPSC, with 48.7% experiencing graft failure.
- Ulcerative colitis post-transplant (HR=2.40) and younger age (HR=0.78) were significantly associated with rPSC. rPSC increased the risk of death by over 4-fold (HR=4.71).
Conclusions:
- Ulcerative colitis following liver transplantation is a significant risk factor for developing rPSC.
- rPSC is associated with increased graft failure, mortality, and re-transplantation rates.
- Early identification and management of UC in PSC patients post-transplant may be critical for improving long-term outcomes.
More Related Videos
Related Concept Videos
01:17Chronic Bowel Disorders: Introduction
930
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
930
01:26Kidney Transplant II: Surgical Procedure
815
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
815